Dr Andrew J Mcwhorter, MD | |
4950 Essen Ln, Suite B, Baton Rouge, LA 70809-3738 | |
(225) 765-5335 | |
(225) 765-5339 |
Full Name | Dr Andrew J Mcwhorter |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 29 Years |
Location | 4950 Essen Ln, Baton Rouge, Louisiana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376524918 | NPI | - | NPPES |
1186970 | Medicaid | LA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 14072R (Louisiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Our Lady Of The Lake Regional Medical Center | Baton rouge, LA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Our Lady Of The Lake Physician Group Llc | 4587849781 | 521 |
News Archive
Responding to the latest NHS performance figures, which show waiting lists growing to the highest levels since records began and cancer patients experiencing record-long waits for treatment, BMA consultants committee chair Dr Rob Harwood said: This latest set of NHS figures show a health service descending into an ever-deepening crisis and closer to a system unfit for purpose.
Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF's KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology's research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).
A new German study published on the preprint server bioRxiv* in June 2020 shows that the drug remdesivir can reduce the replication of SARS-CoV-2 in human intestinal organoids.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today results from a long-term efficacy study of Glybera (alipogene tiparvovec) that showed improved chylomicron metabolism could be used as a biomarker for increased lipoprotein lipase (LPL) activity in those patients missing the gene that produces this protein.
› Verified 6 days ago
Entity Name | Lsuhn Billing Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992975775 PECOS PAC ID: 0446337802 Enrollment ID: O20080409000372 |
News Archive
Responding to the latest NHS performance figures, which show waiting lists growing to the highest levels since records began and cancer patients experiencing record-long waits for treatment, BMA consultants committee chair Dr Rob Harwood said: This latest set of NHS figures show a health service descending into an ever-deepening crisis and closer to a system unfit for purpose.
Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF's KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology's research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).
A new German study published on the preprint server bioRxiv* in June 2020 shows that the drug remdesivir can reduce the replication of SARS-CoV-2 in human intestinal organoids.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today results from a long-term efficacy study of Glybera (alipogene tiparvovec) that showed improved chylomicron metabolism could be used as a biomarker for increased lipoprotein lipase (LPL) activity in those patients missing the gene that produces this protein.
› Verified 6 days ago
Entity Name | Our Lady Of The Lake Physician Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033494943 PECOS PAC ID: 4587849781 Enrollment ID: O20120529000377 |
News Archive
Responding to the latest NHS performance figures, which show waiting lists growing to the highest levels since records began and cancer patients experiencing record-long waits for treatment, BMA consultants committee chair Dr Rob Harwood said: This latest set of NHS figures show a health service descending into an ever-deepening crisis and closer to a system unfit for purpose.
Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF's KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology's research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).
A new German study published on the preprint server bioRxiv* in June 2020 shows that the drug remdesivir can reduce the replication of SARS-CoV-2 in human intestinal organoids.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today results from a long-term efficacy study of Glybera (alipogene tiparvovec) that showed improved chylomicron metabolism could be used as a biomarker for increased lipoprotein lipase (LPL) activity in those patients missing the gene that produces this protein.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Andrew J Mcwhorter, MD 4950 Essen Ln, Suite B, Baton Rouge, LA 70809-3738 Ph: (225) 765-5335 | Dr Andrew J Mcwhorter, MD 4950 Essen Ln, Suite B, Baton Rouge, LA 70809-3738 Ph: (225) 765-5335 |
News Archive
Responding to the latest NHS performance figures, which show waiting lists growing to the highest levels since records began and cancer patients experiencing record-long waits for treatment, BMA consultants committee chair Dr Rob Harwood said: This latest set of NHS figures show a health service descending into an ever-deepening crisis and closer to a system unfit for purpose.
Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF's KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology's research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).
A new German study published on the preprint server bioRxiv* in June 2020 shows that the drug remdesivir can reduce the replication of SARS-CoV-2 in human intestinal organoids.
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today results from a long-term efficacy study of Glybera (alipogene tiparvovec) that showed improved chylomicron metabolism could be used as a biomarker for increased lipoprotein lipase (LPL) activity in those patients missing the gene that produces this protein.
› Verified 6 days ago
Stanley E. Peters, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd, Ste. 2121, Baton Rouge, LA 70810 Phone: 225-767-7200 Fax: 225-767-7386 | |
Samuel Ralph Barber, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 7777 Hennessy Blvd Ste 709, Baton Rouge, LA 70808 Phone: 225-765-7735 Fax: 225-765-9937 | |
Collin Blake Sutton, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd Ste 2222, Baton Rouge, LA 70810 Phone: 225-408-6900 | |
Dr. Christian A. Hall, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8585 Picardy Ave, Ste 512, Baton Rouge, LA 70809 Phone: 225-819-1181 Fax: 225-636-5900 | |
Dr. Frank L. Fazio, M.D., F.A.C.S. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8080 Bluebonnet Blvd Ste 2222, Baton Rouge, LA 70810 Phone: 225-769-2222 Fax: 225-766-2068 | |
Dr. Warner Lee Bruner Iii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 710 Colonial Dr, Baton Rouge, LA 70806 Phone: 225-927-5325 Fax: 225-927-4150 | |
Anna Maria Pou, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4950 Essen Ln, Mbperkins, 4th Floor, Suite A, Baton Rouge, LA 70809 Phone: 225-765-1765 Fax: 225-765-1768 |